Human-Computer Interaction Resource Network
| Vivaglobin.com Primary Immune Deficiency Disease PIDD Subcutaneous Immune Globulin Ig Treatment | |
| Vivaglobin® is a Subcutaneous Immune Globulin Ig treatment FDA approved for Primary Immune Deficiency Disease PIDD. | |
| Keywords : Vivaglobin PIDD primary immune deficiency disease ig subq subcutaneous immune globulin treatment patient therapy |
| Last Update : | 01/December/2011 |
| Google PR : | 4 |
| Indexed pages : | 43 |
| Internal links : | 9 |
| External links : | 7 |
| Archive : | Check how did the site look in the past? |
| Keyword | Occurrences | Percentage |
|---|---|---|
| hizentra | 20 | 3.03% |
| vivaglobin | 17 | 2.58% |
| information | 16 | 2.43% |
| behring | 8 | 1.21% |
| csl | 8 | 1.21% |
| Keyword | Occurrences | Percentage |
|---|---|---|
| csl behring | 8 | 2.43% |
| in the | 6 | 1.82% |
| if you | 5 | 1.52% |
| product information | 5 | 1.52% |
| prescribing information | 5 | 1.52% |
| Keyword | Occurrences | Percentage |
|---|---|---|
| hizentra and vivaglobin | 4 | 1.82% |
| important safety information | 4 | 1.82% |
| the united states | 4 | 1.82% |
| in the united | 4 | 1.82% |
| patient product information | 4 | 1.82% |
| Site IP address : | 12.3.33.73 |
| Server type : | Microsoft-IIS/6.0 |
| Powered by : | ASP.NET |
| Alexa rank : | 18,797,100 |
| Description : |
| systemic itching common variable immune deficiency | 12.09% |
| voice 2 voice csl behring | 12.07% |
| voice 2 voice csl bering | 12.07% |
| hizentra 4f30 patient assistance | 11.88% |
| ig therapy | 11.02% |
| ig maps csl behring | 9.03% |
| 1130 kg per cubic meter to g per ml | 8.25% |
| hizentra | 5.80% |
| location site label\of subcutaneous injection | 4.89% |
| izentra | 4.35% |
| Quantcast rank : | 0 | Average US daily traffic : |
| Compete rank : | 0 |
| Average daily unique visitors : | 0 |
| MyWot rank : | 0 |
| Trustworthiness : | 80 |
| Vendor reliability : | 0 |
| Privacy : | 0 |
| Child safety : | 0 |
|
|
|
|
|
|